Nose | |||||
---|---|---|---|---|---|
Nose / Nasal congestion | |||||
ephedrine hydrochloride | On Formulary | ||||
Inhaled Ephedrine (Primatene Mist)- Non-formulary
Inhaled Ephedrine is not recommended for the treatment of asthma. Please contact the Pharmacy respiratory team for advice if ever prescribed for asthma. Please contact Emergency Medicine Lead Pharmacist for advice if prescribed for patient in ED. |
|||||
Solution for injection | |||||
Ephedrine hydrochloride (Non-proprietary) | |||||
Oral tablet | |||||
Ephedrine hydrochloride (Non-proprietary) | |||||
pseudoephedrine hydrochloride | On Formulary | ||||
Oral solution | |||||
Galpseud (Thornton & Ross Ltd) | |||||
Sudafed Non-Drowsy Decongestant (McNeil Products Ltd) | |||||
Oral tablet | |||||
Galpseud (Thornton & Ross Ltd) | |||||
xylometazoline hydrochloride | On Formulary | ||||
RLH Adult ENT A&E guidelines 2015
|
|||||
Spray | |||||
Otrivine (Haleon UK Trading Ltd) | On Formulary | ||||
RLH Adult ENT A&E guidelines 2015
|
|||||
Sudafed Non-Drowsy Decongestant (McNeil Products Ltd) | |||||
Sudafed Sinus-Ease (McNeil Products Ltd) | |||||
Nasal drops | |||||
Otrivine (Haleon UK Trading Ltd) | |||||
Nose / Nasal infection | |||||
betamethasone with neomycin | On Formulary | ||||
Ear/eye/nose drops solution | |||||
Betnesol-N (RPH Pharmaceuticals AB) | |||||
Cutaneous ointment | |||||
Betamethasone with neomycin (Non-proprietary) | |||||
Cutaneous cream | |||||
Betamethasone with neomycin (Non-proprietary) | |||||
chlorhexidine with neomycin | On Formulary | ||||
Nasal cream | |||||
Naseptin (Alliance Pharmaceuticals Ltd) | |||||
mupirocin | On Formulary | ||||
MRSA Eradication Policy
see attached |
|||||
Nasal ointment | |||||
Bactroban (GlaxoSmithKline UK Ltd) | On Formulary | ||||
Cutaneous ointment | |||||
Mupirocin (Non-proprietary) | |||||
Bactroban (GlaxoSmithKline UK Ltd) | |||||
Cutaneous cream | |||||
Bactroban (GlaxoSmithKline UK Ltd) | |||||
Nose / Nasal inflammation, nasal polyps and rhinitis | |||||
azelastine hydrochloride | On Formulary | ||||
Allergic Rhinitis Pathway
see attached |
|||||
AZELASTINE HYDROCHLORIDE
Combined with oral antihistamine and intranasal corticosteroid for management of severe allergic rhinitis-refer to treatment algorithm for further details |
|||||
Eye drops | |||||
Azelastine hydrochloride (Non-proprietary) | |||||
Optilast (Viatris UK Healthcare Ltd) | |||||
Spray | |||||
Azelair (Viatris UK Healthcare Ltd) | |||||
Rhinolast (Viatris UK Healthcare Ltd) | |||||
beclometasone dipropionate | On Formulary | ||||
Clenil Modulite MDI 100micrograms per actuation
Metered Dose Inhaler. Requires Slow and Steady Breath. Suitable for patients with low Inspiratory effort. All Inhalers should be prescribed by Brand and Device Names. |
|||||
Modified-release tablet | |||||
Clipper (Chiesi Ltd) | |||||
Pressurised inhalation | |||||
Beclu (Lupin Healthcare (UK) Ltd) | |||||
Clenil Modulite (Chiesi Ltd) | |||||
Kelhale (Cipla EU Ltd) | |||||
Qvar (Teva UK Ltd) | |||||
Qvar Autohaler (Teva UK Ltd) | |||||
Qvar Easi-Breathe (Teva UK Ltd) | |||||
Soprobec (Glenmark Pharmaceuticals Europe Ltd) | |||||
Inhalation powder | |||||
Easyhaler (Orion Pharma (UK) Ltd) | |||||
Spray | |||||
Beclometasone dipropionate (Non-proprietary) | On Formulary | ||||
Beconase (GlaxoSmithKline UK Ltd, Omega Pharma Ltd) | On Formulary | ||||
Allergic Rhinitis Pathway
see attached |
|||||
Nasobec (Teva UK Ltd) | On Formulary | ||||
Cutaneous ointment | |||||
Beclometasone dipropionate (Non-proprietary) | |||||
Cutaneous cream | |||||
Beclometasone dipropionate (Non-proprietary) | |||||
betamethasone | On Formulary | ||||
Betesil Medicated Plaster - Inflammatory Skin Disorders (November 2022)
Approved at NEL FPG (Nov 2022) Betesil® 2.250mg medicated plaster is the only potent corticosteroid indicated in adults for the treatment of inflammatory skin disorders. The plaster is licensed to use for a maximum of 30 days at a time, with a maximum of 6 plasters being used at any one time. Plasters may be changed once every 24 hours. Amber-may be prescribed by or on the advice of a specialist |
|||||
Soluble tablet | |||||
Betamethasone (Non-proprietary) | |||||
Solution for injection | |||||
Betamethasone (Non-proprietary) | |||||
Ear/eye/nose drops solution | |||||
Betnesol (RPH Pharmaceuticals AB) | |||||
Vistamethasone (Martindale Pharmaceuticals Ltd) | |||||
Medicated plaster | |||||
Betesil (Derma UK Ltd) | |||||
Cutaneous ointment | |||||
Betamethasone (Non-proprietary) | |||||
Audavate (Accord-UK Ltd) | |||||
Betnovate (GlaxoSmithKline UK Ltd) | |||||
Diprosone (Organon Pharma (UK) Ltd) | |||||
Cutaneous foam | |||||
Bettamousse (RPH Pharmaceuticals AB) | |||||
Cutaneous cream | |||||
Betamethasone (Non-proprietary) | |||||
Audavate (Accord-UK Ltd) | |||||
Betnovate (GlaxoSmithKline UK Ltd) | |||||
Diprosone (Organon Pharma (UK) Ltd) | |||||
Cutaneous liquid | |||||
Betacap (Dermal Laboratories Ltd) | |||||
Betnovate (GlaxoSmithKline UK Ltd) | |||||
Diprosone (Organon Pharma (UK) Ltd) | |||||
budesonide | On Formulary |
NICE TA708 NICE TA937 |
|||
NICE TA 937 -March 2024- Budesonide treating for primary IgA nephropathy (HCD)
Budesonide approved at NEL FPG treating for primary IgA nephropathy (HCD)
Formulary Status: Hospital Only |
|||||
Budesonide 64micrograms/ acuation nasal spray
Budesonide Nasal spray is not our 1st line intranasal corticosteroid. |
|||||
Budesonide orodispersible tablets
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis as per NICE TA708 Approved as Hospital Only. September 2021 DTC. |
|||||
Pulmicort 200mcg Turbohaler
Dry Powder Inhaler. Requires Quick and Deep Breath/ Inspiratory effort. All Inhalers should be prescribed by Brand and Device Names. |
|||||
Orodispersible tablet | |||||
Jorveza (Dr. Falk Pharma UK Ltd) | |||||
Modified-release tablet | |||||
Cortiment (Ferring Pharmaceuticals Ltd) | |||||
Modified-release capsule | |||||
Budesonide (Non-proprietary) | |||||
Kinpeygo (Genus Pharmaceuticals Holdings Ltd) | |||||
Gastro-resistant capsule | |||||
Budenofalk (Dr. Falk Pharma UK Ltd) | |||||
Gastro-resistant granules | |||||
Budenofalk (Dr. Falk Pharma UK Ltd) | |||||
Inhalation powder | |||||
Budelin Novolizer (Viatris UK Healthcare Ltd) | |||||
Easyhaler (Orion Pharma (UK) Ltd) | |||||
Pulmicort Turbohaler (AstraZeneca UK Ltd) | |||||
Barts Health & Local GPs Asthma Prescribing Guidelines
see attached |
|||||
Nebuliser liquid | |||||
Budesonide (Non-proprietary) | |||||
Pulmicort Respules (AstraZeneca UK Ltd) | |||||
Enema | |||||
Entocort (Tillotts Pharma UK Ltd) | |||||
Spray | |||||
Budesonide (Non-proprietary) | |||||
Rectal foam | |||||
Budenofalk (Dr. Falk Pharma UK Ltd) | |||||
desloratadine | Off Formulary | ||||
Oral solution | |||||
Desloratadine (Non-proprietary) | |||||
Neoclarityn (Organon Pharma (UK) Ltd) | |||||
Oral tablet | |||||
Desloratadine (Non-proprietary) | |||||
Neoclarityn (Organon Pharma (UK) Ltd) | |||||
dupilumab |
NICE TA534 NICE TA751 NICE TA955 |
||||
Solution for injection | |||||
Dupixent (Sanofi) | |||||
fexofenadine hydrochloride | On Formulary | ||||
FEXOFENADINE HYDROCHLORIDE
Mild symptoms of allergic rhinitis-refer to treatment algorithm for further details |
|||||
Oral tablet | |||||
Fexofenadine hydrochloride (Non-proprietary) | |||||
Telfast (Sanofi Consumer Healthcare) | |||||
fluticasone | On Formulary | ||||
Fluticasone Nasal Sprays- Please specify brand and Salt
NOTE: Available as Fluticasone PROPIONATE available as Flixonase Brand 50mcg/spray Dose: 100mcg (2sprays) into both nostrils OD up to 100mcg (2sp) into both nostrils BD
Avamys® (Fluticasone FUROATE) 27.5mcg/ spray Dose: 55mcg (2sprays) into both nostrils OD. |
|||||
Pressurised inhalation | |||||
Flixotide Evohaler (GlaxoSmithKline UK Ltd) | |||||
Inhalation powder | |||||
Flixotide Accuhaler (GlaxoSmithKline UK Ltd) | |||||
Spray | |||||
Fluticasone (Non-proprietary) | On Formulary | ||||
Allergic Rhinitis Pathway
Allergic Rhinitis Pathway |
|||||
FLUTICASONE PROPIONATE
Moderate to severe symptoms of allergic rhinitis-refer to treatment algorithm for further details |
|||||
Avamys (GlaxoSmithKline UK Ltd) | |||||
Allergic Rhinitis Pathway
Allergic Rhinitis Pathway |
|||||
Coryen (Alissa Healthcare Research Ltd) | |||||
Flixonase (GlaxoSmithKline UK Ltd, Haleon UK Trading Ltd) | |||||
Nasofan (Teva UK Ltd) | |||||
Nasal drops | |||||
Fluticasone (Non-proprietary) | |||||
Cutaneous ointment | |||||
Cutivate (GlaxoSmithKline UK Ltd) | |||||
Cutaneous cream | |||||
Fluticasone (Non-proprietary) | |||||
fluticasone with azelastine | On Formulary | ||||
Spray | |||||
Dymista (Viatris UK Healthcare Ltd) | |||||
ipratropium bromide | On Formulary | ||||
Pressurised inhalation | |||||
Atrovent (Boehringer Ingelheim Ltd) | |||||
Inhalvent (Alissa Healthcare Research Ltd) | |||||
Nebuliser liquid | |||||
Ipratropium bromide (Non-proprietary) | |||||
Atrovent UDV (Boehringer Ingelheim Ltd) | |||||
Spray | |||||
Ipratropium bromide (Non-proprietary) | |||||
ketotifen | Off Formulary | ||||
Oral solution | |||||
Zaditen (CD Pharma Srl) | |||||
Eye drops | |||||
Ketofall (Scope Ophthalmics Ltd) | |||||
Zaditen (Thea Pharmaceuticals Ltd) | |||||
Oral tablet | |||||
Zaditen (CD Pharma Srl) | |||||
mometasone furoate | On Formulary | ||||
Inhalation powder | |||||
Asmanex Twisthaler (Organon Pharma (UK) Ltd) | |||||
Spray | |||||
Mometasone furoate (Non-proprietary) | |||||
Nasonex (Organon Pharma (UK) Ltd) | |||||
Allergic Rhinitis Pathway
see attached |
|||||
Cutaneous ointment | |||||
Mometasone furoate (Non-proprietary) | |||||
Elocon (Organon Pharma (UK) Ltd) | |||||
Cutaneous cream | |||||
Mometasone furoate (Non-proprietary) | |||||
Elocon (Organon Pharma (UK) Ltd) | |||||
Cutaneous liquid | |||||
Elocon (Organon Pharma (UK) Ltd) | |||||
mometasone furoate with olopatadine | |||||
Spray | |||||
Ryaltris (Glenmark Pharmaceuticals Europe Ltd) | |||||
rupatadine | Off Formulary | ||||
Oral tablet | |||||
Rupatadine (Non-proprietary) | |||||
triamcinolone acetonide | On Formulary | ||||
Suspension for injection | |||||
Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) | |||||
Kenalog (Bristol-Myers Squibb Pharmaceuticals Ltd) | |||||
Spray | |||||
Nasacort (Sanofi Consumer Healthcare) |